HOUSTON, TX / ACCESS Newswire / February 12, 2026 / EON Resources Inc. (NYSE American:EONR) ("EON" or the "Company") is ...

The year ended strongly with an important milestone; the license and option agreement with Moderna, which is an important validation of our technology and has created favourable conditions for 2026 an ...

A breakthrough personalized mRNA cancer vaccine that trains the immune system to target patients' unique tumor mutations is showing promising results. Five-year trial data show the risk of recurrence ...

Moderna Chief Medical Officer Jacqueline Miller, M.D., is stepping down after a little more than a year in the role. As of publication, Moderna has not responded to Fierce Biotech’s questions about a ...

Moderna (MRNA) has posted over 20% gain this week, putting it squarely in the momentum spotlight among biotech names. The stock is up about 9% so far today, as it reached a new 52-week high on ...

Moderna Inc.’s chief executive officer said the company doesn’t plan to invest in new late-stage vaccine trials because of growing opposition to immunizations from US officials. “You cannot make a ...

Add Yahoo as a preferred source to see more of our stories on Google. Moderna and MSD's mRNA cancer vaccine A combination of Moderna and MSD's personalised cancer vaccine, intismeran autogene, and MSD ...

A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin cancer after five years, new data confirming its prolonged benefit show.

(RTTNews) - Moderna (MRNA) heads into 2026 with stronger finances and a crowded late-stage pipeline after an aggressive cost reset in 2025 and a slate of regulatory and clinical milestones lined up ...

Jan 12 (Reuters) - Moderna (MRNA.O), opens new tab said on Monday it expects to report around $1.9 billion in sales for 2025, putting it near the upper end of its previously projected $1.6 billion to ...

What To Know: Moderna said it expects 2025 revenue of approximately $1.9 billion, which is $100 million above the midpoint previously communicated during its third-quarter earnings call. The company ...